Vitamin B12, cognition, and brain MRI measures

Objective: To investigate the interrelations of serum vitamin B12 markers with brain volumes, cerebral infarcts, and performance in different cognitive domains in a biracial population sample cross-sectionally. Methods: In 121 community-dwelling participants of the Chicago Health and Aging Project, serum markers of vitamin B12 status were related to summary measures of neuropsychological tests of 5 cognitive domains and brain MRI measures obtained on average 4.6 years later among 121 older adults. Results: Concentrations of all vitamin B12–related markers, but not serum vitamin B12 itself, were associated with global cognitive function and with total brain volume. Methylmalonate levels were associated with poorer episodic memory and perceptual speed, and cystathionine and 2-methylcitrate with poorer episodic and semantic memory. Homocysteine concentrations were associated with decreased total brain volume. The homocysteine-global cognition effect was modified and no longer statistically significant with adjustment for white matter volume or cerebral infarcts. The methylmalonate-global cognition effect was modified and no longer significant with adjustment for total brain volume. Conclusions: Methylmalonate, a specific marker of B12 deficiency, may affect cognition by reducing total brain volume whereas the effect of homocysteine (nonspecific to vitamin B12 deficiency) on cognitive performance may be mediated through increased white matter hyperintensity and cerebral infarcts. Vitamin B12 status may affect the brain through multiple mechanisms.

[1]  Yung-Yee Chang,et al.  Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients , 2009, Journal of the Neurological Sciences.

[2]  P. Pietrini,et al.  Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. , 1996, Archives of general psychiatry.

[3]  B Horwitz,et al.  Age-related differences in volumes of subcortical nuclei, brain matter, and cerebrospinal fluid in healthy men as measured with magnetic resonance imaging. , 1992, Archives of neurology.

[4]  Abderrahim Oulhaj,et al.  Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial , 2010, PloS one.

[5]  L. Allen.  How common is vitamin B-12 deficiency? , 2009, The American journal of clinical nutrition.

[6]  D. Bennett,et al.  The association of magnetic resonance imaging measures with cognitive function in a biracial population sample. , 2010, Archives of neurology.

[7]  J. Haxby,et al.  Lack of age-related differences in temporal lobe volume of very healthy adults. , 1994, AJNR. American journal of neuroradiology.

[8]  M. Kivipelto,et al.  Apolipoprotein E, B vitamins, and cognitive function in older adults. , 2005, The journals of gerontology. Series B, Psychological sciences and social sciences.

[9]  Denis A. Evans,et al.  Biracial population study of mortality in mild cognitive impairment and Alzheimer disease. , 2009, Archives of neurology.

[10]  A. Smith,et al.  Plasma vitamin B12 status and cerebral white-matter lesions , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[11]  R. Sacco,et al.  Total homocysteine and cognition in a tri-ethnic cohort , 2004, Neurology.

[12]  Ning Qiao,et al.  High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. , 2005, The American journal of clinical nutrition.

[13]  C. DeCarli,et al.  Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study. , 1999, Stroke.

[14]  R. Allen,et al.  Elevation of 2-methylcitric acid I and II levels in serum, urine, and cerebrospinal fluid of patients with cobalamin deficiency. , 1993, Metabolism: clinical and experimental.

[15]  Faith M. Gunning-Dixon,et al.  Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study , 2003, Neuropsychologia.

[16]  C. DeCarli,et al.  Total Homocysteine Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study , 2005, Stroke.

[17]  R. Allen,et al.  Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  David A Bennett,et al.  Design of the Chicago Health and Aging Project (CHAP). , 2003, Journal of Alzheimer's disease : JAD.

[19]  D. Teichberg,et al.  Local histogram correction of MRI spatially dependent image pixel intensity nonuniformity , 1996, Journal of magnetic resonance imaging : JMRI.

[20]  A. Smith,et al.  Vitamin B12 status and rate of brain volume loss in community-dwelling elderly , 2008, Neurology.

[21]  C. DeCarli,et al.  Impact of Apolipoprotein E ε4 and Vascular Disease on Brain Morphology in Men From the NHLBI Twin Study , 1999 .

[22]  R. Clarke,et al.  Clinical relevance of low serum vitamin B12 concentrations in older people: the Banbury B12 study. , 2006, Age and ageing.

[23]  J. Drulovic,et al.  A 44-month clinical-brain MRI follow-up in a patient with B12 deficiency , 1997, Neurology.

[24]  D. Harvey,et al.  Measures of brain morphology and infarction in the framingham heart study: establishing what is normal , 2005, Neurobiology of Aging.

[25]  W. Jagust,et al.  Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. , 2007, The American journal of clinical nutrition.

[26]  G. Scalabrino.  Cobalamin (vitamin B12) in subacute combined degeneration and beyond: traditional interpretations and novel theories , 2005, Experimental Neurology.

[27]  Eric E. Smith,et al.  Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. , 2008, Archives of neurology.

[28]  David A. Bennett,et al.  Decision Rules Guiding the Clinical Diagnosis of Alzheimer’s Disease in Two Community-Based Cohort Studies Compared to Standard Practice in a Clinic-Based Cohort Study , 2006, Neuroepidemiology.

[29]  Denis A. Evans,et al.  Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline , 2009, Neurology.

[30]  Sudha Seshadri,et al.  Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .

[31]  Matthijs Oudkerk,et al.  Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam scan study , 2002, Annals of neurology.

[32]  A David Smith,et al.  Plasma folate concentration and cognitive performance: Rotterdam Scan Study. , 2007, The American journal of clinical nutrition.

[33]  B. Horwitz,et al.  Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. , 1992, Journal of computer assisted tomography.

[34]  C. Dufouil,et al.  Homocysteine, white matter hyperintensities, and cognition in healthy elderly people , 2003, Annals of neurology.

[35]  R. Clarke,et al.  Low vitamin B-12 status and risk of cognitive decline in older adults. , 2007, The American journal of clinical nutrition.

[36]  D. Harvey,et al.  Anatomical Mapping of White Matter Hyperintensities (WMH): Exploring the Relationships Between Periventricular WMH, Deep WMH, and Total WMH Burden , 2005, Stroke.